0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Othe-1N392
Home | Market Reports | Health| Medical Facilities & Services
Global Polymerase Chain Reaction PCR for Point of Care POC Diagnostics Market Insights Forecast to 2028
BUY CHAPTERS

Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Research Report 2025

Code: QYRE-Othe-1N392
Report
September 2025
Pages:70
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size

The global market for Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics was valued at US$ 4161 million in the year 2024 and is projected to reach a revised size of US$ 7060 million by 2031, growing at a CAGR of 8.0% during the forecast period.

Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market

Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market

Point of Care (PoC) molecular diagnostics market is poised to witness robust growth over the forecast period. Increasing infectious diseases incidence coupled with growing public awareness levels pertaining to pre-disease detection to control its occurrence will drive PoC molecular diagnostics market growth.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics.
The Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Report

Report Metric Details
Report Name Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market
Accounted market size in year US$ 4161 million
Forecasted market size in 2031 US$ 7060 million
CAGR 8.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Real Time PCR
  • DNA/RNA Purification
Segment by Application
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Atlas Genetics, Cepheid, Fluxergy, Roche Diagnostics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market growing?

Ans: The Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market witnessing a CAGR of 8.0% during the forecast period 2025-2031.

What is the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market size in 2031?

Ans: The Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market size in 2031 will be US$ 7060 million.

Who are the main players in the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market report?

Ans: The main players in the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market are Abbott Laboratories, Atlas Genetics, Cepheid, Fluxergy, Roche Diagnostics

What are the Application segmentation covered in the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market report?

Ans: The Applications covered in the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market report are Hospitals, Ambulatory Surgical Centers, Diagnostic Centers

What are the Type segmentation covered in the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market report?

Ans: The Types covered in the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market report are Real Time PCR, DNA/RNA Purification

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Real Time PCR
1.2.3 DNA/RNA Purification
1.3 Market by Application
1.3.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Perspective (2020-2031)
2.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Growth Trends by Region
2.2.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Dynamics
2.3.1 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Industry Trends
2.3.2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Drivers
2.3.3 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Challenges
2.3.4 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Players by Revenue
3.1.1 Global Top Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue
3.4 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Concentration Ratio
3.4.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue in 2024
3.5 Global Key Players of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Head office and Area Served
3.6 Global Key Players of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics, Product and Application
3.7 Global Key Players of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Breakdown Data by Type
4.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Forecasted Market Size by Type (2026-2031)
5 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Breakdown Data by Application
5.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size (2020-2031)
6.2 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2020-2025)
6.4 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size (2020-2031)
7.2 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2020-2025)
7.4 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size (2020-2031)
9.2 Latin America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Atlas Genetics
11.2.1 Atlas Genetics Company Details
11.2.2 Atlas Genetics Business Overview
11.2.3 Atlas Genetics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Introduction
11.2.4 Atlas Genetics Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2020-2025)
11.2.5 Atlas Genetics Recent Development
11.3 Cepheid
11.3.1 Cepheid Company Details
11.3.2 Cepheid Business Overview
11.3.3 Cepheid Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Introduction
11.3.4 Cepheid Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2020-2025)
11.3.5 Cepheid Recent Development
11.4 Fluxergy
11.4.1 Fluxergy Company Details
11.4.2 Fluxergy Business Overview
11.4.3 Fluxergy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Introduction
11.4.4 Fluxergy Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2020-2025)
11.4.5 Fluxergy Recent Development
11.5 Roche Diagnostics
11.5.1 Roche Diagnostics Company Details
11.5.2 Roche Diagnostics Business Overview
11.5.3 Roche Diagnostics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Introduction
11.5.4 Roche Diagnostics Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2020-2025)
11.5.5 Roche Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Real Time PCR
 Table 3. Key Players of DNA/RNA Purification
 Table 4. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share by Region (2020-2025)
 Table 8. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share by Region (2026-2031)
 Table 10. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Trends
 Table 11. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Drivers
 Table 12. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Challenges
 Table 13. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Restraints
 Table 14. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share by Players (2020-2025)
 Table 16. Global Top Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics as of 2024)
 Table 17. Ranking of Global Top Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics, Headquarters and Area Served
 Table 20. Global Key Players of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics, Product and Application
 Table 21. Global Key Players of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Market Share by Type (2020-2025)
 Table 25. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Market Share by Type (2026-2031)
 Table 27. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Market Share by Application (2020-2025)
 Table 29. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Market Share by Application (2026-2031)
 Table 31. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Abbott Laboratories Company Details
 Table 47. Abbott Laboratories Business Overview
 Table 48. Abbott Laboratories Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product
 Table 49. Abbott Laboratories Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2020-2025) & (US$ Million)
 Table 50. Abbott Laboratories Recent Development
 Table 51. Atlas Genetics Company Details
 Table 52. Atlas Genetics Business Overview
 Table 53. Atlas Genetics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product
 Table 54. Atlas Genetics Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2020-2025) & (US$ Million)
 Table 55. Atlas Genetics Recent Development
 Table 56. Cepheid Company Details
 Table 57. Cepheid Business Overview
 Table 58. Cepheid Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product
 Table 59. Cepheid Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2020-2025) & (US$ Million)
 Table 60. Cepheid Recent Development
 Table 61. Fluxergy Company Details
 Table 62. Fluxergy Business Overview
 Table 63. Fluxergy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product
 Table 64. Fluxergy Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2020-2025) & (US$ Million)
 Table 65. Fluxergy Recent Development
 Table 66. Roche Diagnostics Company Details
 Table 67. Roche Diagnostics Business Overview
 Table 68. Roche Diagnostics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product
 Table 69. Roche Diagnostics Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2020-2025) & (US$ Million)
 Table 70. Roche Diagnostics Recent Development
 Table 71. Research Programs/Design for This Report
 Table 72. Key Data Information from Secondary Sources
 Table 73. Key Data Information from Primary Sources
 Table 74. Authors List of This Report


List of Figures
 Figure 1. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Picture
 Figure 2. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share by Type: 2024 VS 2031
 Figure 4. Real Time PCR Features
 Figure 5. DNA/RNA Purification Features
 Figure 6. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share by Application: 2024 VS 2031
 Figure 8. Hospitals Case Studies
 Figure 9. Ambulatory Surgical Centers Case Studies
 Figure 10. Diagnostic Centers Case Studies
 Figure 11. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Report Years Considered
 Figure 12. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share by Region: 2024 VS 2031
 Figure 15. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share by Players in 2024
 Figure 16. Global Top Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue in 2024
 Figure 18. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share by Country (2020-2031)
 Figure 20. United States Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share by Country (2020-2031)
 Figure 24. Germany Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share by Region (2020-2031)
 Figure 32. China Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share by Country (2020-2031)
 Figure 40. Mexico Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share by Country (2020-2031)
 Figure 44. Turkey Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Abbott Laboratories Revenue Growth Rate in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2020-2025)
 Figure 48. Atlas Genetics Revenue Growth Rate in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2020-2025)
 Figure 49. Cepheid Revenue Growth Rate in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2020-2025)
 Figure 50. Fluxergy Revenue Growth Rate in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2020-2025)
 Figure 51. Roche Diagnostics Revenue Growth Rate in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2020-2025)
 Figure 52. Bottom-up and Top-down Approaches for This Report
 Figure 53. Data Triangulation
 Figure 54. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture